e-Drug3D 1218 |
GUANETHIDINE DISCONTINUED
|
cas 55-65-2 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
PK parameters t1/2 SEVERAL DAYS |
Target TARGET NITRIC OXIDE SYNTHASE (PMID10889350) |
DrugCentral Sodium-dependent noradrenaline transporter UNIPROT P23975 SLC6A2 |
Download SDF file | 2-[2-(azocan-1-yl)ethyl]guanidine Formula: Calculated chemical properties: MW 198.32 NB_atoms 14 XLogP 0.53 PSA 61.688 NB_HD 4 NB_HA 4 fsp3 0.90 Lipinski(0=no;1=yes) 1 |
FDA NDA 013553 (pdf not found) INN (GUANETHIDINE MONOSULFATE ; HYDROCHLOROTHIAZIDE) ESIMIL (NOVARTIS) APPROVAL= - YEAR= 0 DISCONTINUED NDA 086113 (pdf not found) INN (GUANETHIDINE MONOSULFATE) GUANETHIDINE MONOSULFATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED NDA 086114 (pdf not found) INN (GUANETHIDINE MONOSULFATE) GUANETHIDINE MONOSULFATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED NDA 012329 (pdf not found) INN (GUANETHIDINE MONOSULFATE) ISMELIN (NOVARTIS) APPROVAL= AP YEAR= 1960 DISCONTINUED |
Other links: |